Found 10 results
↓ CSVName | Type of Offering | Accepted Date |
---|---|---|
Neurelis, Inc.
See All Filings
|
D | 2017-01-06 11:44:24 |
Amount To Be Raised
$20,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001481632
Filed Document
0001140361-17-000927
Exclusions or Exemptions
506b
Accepted Date
2017-01-06 11:44:24
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Neurelis, Inc.
See All Filings
|
D | 2018-08-24 13:59:14 |
Amount To Be Raised
$15,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001481632
Filed Document
0001567619-18-001767
Exclusions or Exemptions
506b
Accepted Date
2018-08-24 13:59:14
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Neurelis, Inc.
See All Filings
|
D | 2018-11-20 17:00:10 |
Amount To Be Raised
$40,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001481632
Filed Document
0001567619-18-006774
Exclusions or Exemptions
506b
Accepted Date
2018-11-20 17:00:10
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Neurelis, Inc.
See All Filings
|
D | 2021-03-08 08:42:24 |
Amount To Be Raised
$120,021,902
Associated Brokers / Dealers
N/A
CIK Number
0001481632
Filed Document
0001567619-21-005773
Exclusions or Exemptions
506b
Accepted Date
2021-03-08 08:42:24
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Neurelis, Inc.
See All Filings
|
D/A | 2020-10-16 11:03:02 |
Amount To Be Raised
$42,098,007
Associated Brokers / Dealers
N/A
CIK Number
0001481632
Filed Document
0001567619-20-017895
Exclusions or Exemptions
506b
Accepted Date
2020-10-16 11:03:02
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Neurelis, Inc.
See All Filings
|
D | 2010-02-02 |
Amount To Be Raised
$2,400,000
Associated Brokers / Dealers
N/A
CIK Number
0001481632
Filed Document
0001481632-10-000001
Exclusions or Exemptions
N/A
Accepted Date
2010-02-02
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Neurelis, Inc.
See All Filings
|
D | 2015-07-16 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001481632
Filed Document
0001140361-15-027739
Exclusions or Exemptions
506b
Accepted Date
2015-07-16
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Neurelis, Inc.
See All Filings
|
D | 2011-09-30 |
Amount To Be Raised
$1,083,950
Associated Brokers / Dealers
N/A
CIK Number
0001481632
Filed Document
0001481632-11-000001
Exclusions or Exemptions
N/A
Accepted Date
2011-09-30
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Neurelis, Inc.
See All Filings
|
D/A | 2017-12-07 11:19:41 |
Amount To Be Raised
$20,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001481632
Filed Document
0001140361-17-045270
Exclusions or Exemptions
506b
Accepted Date
2017-12-07 11:19:41
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Neurelis, Inc.
See All Filings
|
D | 2020-02-03 15:54:16 |
Amount To Be Raised
$15,348,001
Associated Brokers / Dealers
N/A
CIK Number
0001481632
Filed Document
0001567619-20-001916
Exclusions or Exemptions
506b
Accepted Date
2020-02-03 15:54:16
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|